Cachexia index as a potential biomarker for cancer cachexia and a prognostic indicator in diffuse large B‐cell lymphoma

BACKGROUND: Cancer cachexia is known to adversely affect the clinical course in patients with malignant lymphoma. The cachexia index (CXI) is a potential biomarker of cancer cachexia, and its implications for the prognosis and treatment outcome of lung cancer and aggressive lymphoma has been assesse...

Descripción completa

Detalles Bibliográficos
Autores principales: Go, Se‐Il, Park, Mi Jung, Park, Sungwoo, Kang, Myoung Hee, Kim, Hoon‐Gu, Kang, Jung Hun, Kim, Jung Hoon, Lee, Gyeong‐Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718032/
https://www.ncbi.nlm.nih.gov/pubmed/34676685
http://dx.doi.org/10.1002/jcsm.12837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718032/
https://www.ncbi.nlm.nih.gov/pubmed/34676685
http://dx.doi.org/10.1002/jcsm.12837

Ejemplares similares